臧思婷,潘 玉,陈 苗,张 岗

乳腺癌凭借高发病率、癌症相关高死亡率而成为医学研究和临床治疗的焦点。微血管密度（microvessel density，MVD），作为肿瘤缺氧微环境诱导的血管生成的关键病理指标，与乳腺癌的侵袭性、治疗疗效、远期预后等均显示出显著的相关性。尽管MVD的测量对于临床决策至关重要，但其作为一种有创性检查，目前尚缺乏标准化的抗体选择和评估标准。鉴于此，本研究旨在深入探讨不同免疫组化抗体在MVD检测中的表现，评估与MVD相关的磁共振成像参数并揭示其相关性，为无创影像学技术在乳腺癌诊断中的应用提供科学依据，为乳腺癌的治疗提供新的策略，从而提高患者的治疗效果和生活质量。

乳腺癌；微血管密度；磁共振

[1] 梁泓冰,张丽娜,宁宁,等.乳腺癌血管生成的MRI影像学评价研究进展[J].磁共振成像,2023,14(04):160-165+180. [2] 刘翱宇,张红霞,张斓,等.超快速动态对比增强磁共振成像在乳腺病变诊断中的研究进展[J].现代肿瘤医学,2024,32(04):770-773. [3] Xiao J,Rahbar H,Hippe DS,et al.Dynamic contrast-enhanced breast MRI features correlate with invasive breast cancer angiogenesis[J]. NP J Breast Cancer,2021,7(1):42. [4] Kim SH,Lee HS,Kang BJ,et al.Dynamic Contrast-Enhanced MRI Perfusion Parameters as Imaging Biomarkers of Angiogenesis[J]. PLoS One,2016,11(12):e0168632. [5] 钟咏华,范梅花,董敏,等.常规超声检查和超声造影在乳腺癌微血管密度检测中的应用分析[J].医学影像学杂志, 2024,34(02):159-161. [6] Mori N,Abe H,Mugikura S,et al.Ultrafast Dynamic Contrast-Enhanced Breast MRI:Kinetic Curve Assessment Using Empirical Mathematical Model Validated with Histological Microvessel Density[J].Acad Radiol,2019,26(7):e141-e149. [7] 周玉,卢冠铭.CD31､CD105在乳腺癌中的研究现状[J].现代医学与健康研究电子杂志,2024,8(05):19-23. [8] Fateha N,Shah MB,Asafudullah SM,et al.Determination of Microvessel Density by CD34 Immunoreactivity in Female Breast Cancer and its Relation with Grading and Staging[J].J Surg Oncol,2022,10(10):1815-1821. [9] Ahmad MA,Anand K,Afreen A,et al.Evaluation of Prognostic Factors in Triple Negative Breast Cancer Patients with Emphasis on Angiogenesis[J].J Pharm Res Health Care,2020,12(3):107-117. [10] Dharambir K,Amanjit B,Santosh I,et al.Heterogeneity of the Tumor Microenvironment Across Molecular Subtypes of Breast Cancer[J].Appl Immunohistochem Mol Morphol,2023,31(8):533-543. [11] Vijayasree V,Ramana VS,Kumar AR,et al.Correlation of microvessel density with tumor type,tumor size,histological grade and lymph node status of breast carcinoma[J].Indian J Pathol Oncol,2018,5(2):318-325. [12] 杜阳阳.血管内皮生长因子-D､微血管密度及微淋巴管密度的表达与乳腺癌临床病理特征的相关性[J].国际免疫学杂志, 2017,40(3):282-286. [13] Bhatia JK,Chaudhary T,Boruah D,Bharadwaj R.Study of angiogenesis in invasive breast carcinoma by morphometry and immunohistochemistry.Med J Armed Forces India.2022,78(3):345-354.. [14] 杨阳,杨晓芬,黄培森,等.橙皮苷对雌激素和孕激素诱导雌性大鼠乳腺增生的抑制作用[J].中国临床药理学杂志,2024,40(1):77-81. [15] 宋莹,李江龙.ER､PR､HER-2及Ki-67表达与乳腺癌患者新辅助化疗后病理完全缓解的相关性分析[J].中国医学创新, 2024,21(27):139-143. [16] Felix AS,Lenz P,Pfeiffer RM,et al.Relationships between mammographic density,tissue microvessel density,and breast biopsy diagnosis[J].Breast Cancer Res,2016,18(1):88. [17] 杨珂,苗重昌.基于不同磁共振成像技术的影像组学在乳腺病变鉴别诊断中的应用[J].磁共振成像,2024,15(09):189-193+200. [18] 罗雨晴,陈科威,潘君龙,等.超快速动态增强MRI在乳腺癌中的研究进展[J].影像诊断与介入放射学,2024,33(2):134-140. [19] Bennani-Baiti B,Pinker K,Zimmermann M,et al.Non-Invasive Assessment of Hypoxia and Neovascularization with MRI for Identification of Aggressive Breast Cancer[J].Cancers(Basel),2020,12(8):2024. [20] 谢飞跃,林竹强,张庭庭.MRI定量参数对不同乳腺癌分子亚型的鉴别诊断价值研究[J].实用放射学杂志,2022,38(12):1976-1981.

点击下载PDF